JYOTHYLAB — Jyothy Labs Balance Sheet
0.000.00%
- IN₹116.24bn
- IN₹109.23bn
- IN₹28.47bn
- 81
- 19
- 53
- 51
Annual balance sheet for Jyothy Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 719 | 760 | 2,778 | 6,099 | 7,481 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,345 | 1,879 | 1,633 | 2,257 | 3,043 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,248 | 7,241 | 7,751 | 11,392 | 14,114 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,658 | 3,392 | 3,394 | 3,469 | 3,712 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 19,560 | 20,228 | 20,617 | 24,009 | 26,908 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,727 | 5,207 | 4,063 | 4,805 | 5,108 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,274 | 5,792 | 5,127 | 5,926 | 6,413 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 14,286 | 14,436 | 15,490 | 18,083 | 20,495 |
| Total Liabilities & Shareholders' Equity | 19,560 | 20,228 | 20,617 | 24,009 | 26,908 |
| Total Common Shares Outstanding |